Showing results (131-140 of 348) with videos related to

Sort By:
Pageof 35
ACS Nano|January 11, 2024
Intratumoral Biosynthesis of Gold Nanoclusters by Pancreatic Cancer to Overcome Delivery Barriers to RadiosensitizationAaron S Schwartz-Duval, Yuri Mackeyev, Iqbal Mahmud, et al.
Cells|July 28, 2019
Prognostic Value of miRNAs in Head and Neck Cancers: A Comprehensive Systematic and Meta-AnalysisChellan Kumarasamy, Madurantakam Royam Madhav, Shanthi Sabarimurugan, et al.
Molecular Cancer Therapeutics|August 10, 2019
Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic DysregulationPankaj K Singh, Amit A Deorukhkar, Bhanu P Venkatesulu, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
High-Content Clonogenic Survival Screen to Identify Chemoradiation SensitizersRui Ye, Yawei Qiao, Pankaj K Singh, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2015
Roadmap to Clinical Use of Gold Nanoparticles for Radiation SensitizationJan Schuemann, Ross Berbeco, Devika B Chithrani, et al.
Scientific Reports|October 9, 2025
Comprehensive analysis of the tumor targeting efficiency of functionalized nanoparticles in an immunocompetent environmentNolan Jackson, Nasry Bouzeineddine, Daniel Cecchi, et al.
Mutation Research|August 25, 2010
Differential activation of NF-κB and nitric oxide in lymphocytes regulates in vitro and in vivo radiosensitivityDeepak Sharma, Santosh K Sandur, R Rashmi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2012
Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patientsTina Marie Briere, Christopher H Crane, Sam Beddar, et al.
Annals of Surgical Oncology|November 6, 2008
Attempted salvage resection for recurrent gastric or gastroesophageal cancerBrian Badgwell, Janice N Cormier, Yan Xing, et al.
Frontiers in Oncology|June 6, 2022
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent GlioblastomaKshama Gupta, Jeremy C Jones, Virginea De Araujo Farias, et al.
Pageof 35